US · PFSA
Profusa, Inc. Common Stock
- Sector
- Healthcare · Medical - Equipment & Services
- Headquarters
- EmeryVille, CA 94608
- Website
- profusa.com
Price · as of 2026-07-06
$0.11
Market cap 194.6K
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| PFSA | Profusa, Inc. Common Stoc… | $0.09 | 194.6K | — | — | — | — | — | — | — | — | — |
| ACXP | Acurx Pharmaceuticals, In… | $1.99 | 3.15M | — | — | — | — | -0.55 | 12.65 | — | — | — |
| ADIL | Adial Pharmaceuticals, In… | $2.53 | 2.43M | — | — | — | — | -1.06 | 3.43 | — | -1.23 | — |
| APRE | Aprea Therapeutics, Inc. | $0.93 | 6.04M | +3,731% | +71% | — | — | -0.99 | 0.66 | 8.54 | 0.70 | 15763.00% |
| BCDA | BioCardia, Inc. | $0.92 | 5.32M | +9,002% | +15% | — | +23,858% | -0.90 | 8.59 | 123.95 | -0.73 | -8784.00% |
| BFRI | Biofrontera Inc. | $0.86 | 11.01M | — | — | — | — | — | — | — | — | — |
| CHEK | Check-Cap Ltd. | $1.86 | 10.88M | — | — | — | — | -0.19 | -3.24 | — | -0.49 | — |
| HCWB | HCW Biologics Inc. | $2.09 | 4.36M | — | — | — | +15,408% | — | — | — | — | — |
| LUCY | Innovative Eyewear, Inc. | $1.04 | 4.15M | — | — | — | — | — | — | — | — | — |
| SBFM | Sunshine Biopharma, Inc. | $0.32 | 1.59M | — | — | — | — | — | — | — | — | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.11) − 1 = — (DCF, example).